38
J. El Haj Hassan et al. / Journal of Organometallic Chemistry 823 (2016) 34e39
2.54 (m, 1H, CH(CH3)2), 1.98 (s, 3H), 1.07 (d, 3J ¼ 6.9, 6H, (CH3)2CH),
0.99 (d, 3J ¼ 6.9, 6H, (CH3)2CH).
140.3 (p-Py), 138.8, 137.7, 136.7, 136.5, 136.2, 129.0, 128.3, 128.3,
127.6,126.8,126.6,124.2,123.4, 96.9 (m-Py), 93.3 (m-Py), 50.6 (CH2),
33.6 (CH(CH3)2), 28.0 (CH(CH3)2), 24.2 (CH(CH3)2), 22.8 (CH(CH3)2),
18.0 (NC(CH3)N), 17.7 ((CH3)2C6H3N). Anal. Calcd for C34H41N3O: C,
80.43; H, 8.14; N, 8.28. Found: C, 80.55; H, 8.27; N, 8.85.
4.5. 2-(N-(6-(2,6-dimethylphenylamino)pyridin-2-yl)-N-(2,6-
dimethylphenyl)carbamoyl)-4,6-di-isopropylphenyl acetate
To a solution of bis(dimethylphenylamino)pyridine (4.61 g,
14.5 mmol) in o-xylene (20 mL) was added Et3N (6.1 mL,
43.6 mmol) under argon. A solution of 2-(chlorocarbonyl)-4,6-
diisopropylphenyl acetate (18.9 mmol) in o-xylene (10 mL) was
transferred under argon to the reaction mixture under rigorous
stirring. The reaction mixture was refluxed at 190 ꢁC overnight. The
solvent was removed under reduced pressure. The resulting black
oil was dissolved in CH2Cl2 (50 mL) and eluted through an Al2O3
pad using a 1:1 mixture of CH2Cl2eheptane as eluent. The eluate
was concentrated under vacuum and the product was recrystal-
lized from heptane to afford the desired product as a brownish
crystalline material (4.3 g, 52%). 1H NMR (400 MHz, C6D6, 298 K):
4.8. {NMe2NNMe2CiPr2O}Sc(CH2SiMe3)(THF) (1-Sc)
To a solution of 1-H2 (300 mg, 0.591 mmol) in toluene (5 mL)
was added
a solution of Sc(CH2SiMe3)3(THF)2 (266.4 mg,
0.591 mmol) in toluene (5 mL) at ꢀ30 ꢁC. The reaction mixture was
stirred overnight at room temperature. Volatiles were evaporated
under vacuum and the crude solid residue was dried overnight,
washed with hexane (10 mL), to afford the desired product as
white-yellow powder of 1-Sc (382 mg, 91%). 1H NMR (400 MHz,
C6D6, 298 K):
d
7.20e6.80 (m, 7H, Ar), 6.70 (t, 3J ¼ 8.1, 1H, p-Py), 6.52
(d, 4J ¼ 2.3, 1H, Ar), 6.38 (d, 2J ¼ 15.1, 1H, CHH), 5.07 (d, 3J ¼ 8.0, 1H,
m-Py), 5.02 (d, 3J ¼ 8.0, 1H, m-Py), 4.32 (d, 2J ¼ 15.1, 1H, CHH), 3.85
(br m, 4H, THF), 3.62 (hept, 3J ¼ 7.0, 1H, CH(CH3)2), 2.73 (hept,
3J ¼ 7.0, 1H, CH(CH3)2), 2.48 (s, 3H, (CH3)2C6H3N), 2.26 (s, 3H,
(CH3)2C6H3N), 2.04 (s, 3H, (CH3)2C6H3N), 1.64 (s, 3H, (CH3)2C6H3N),
1.49 (m, 6H, (CH3)2CH), 1.18 (d, 3J ¼ 6.9, 3H, (CH3)2CH), 1.15 (d,
3J ¼ 7.0, 3H, (CH3)2CH), 1.08 (br m, 4H, THF), 0.53 (d, 2J ¼ 11.8, 1H,
d
7.20 (s,1H, Ar), 6.93 (m, 7H, Ar þ p-Py), 6.68 (br m, 2H, Ar þ m-Py),
5.71 (br s, 1H, NH), 5.45 (m, 1H, m-Py), 3.17 (hept, 3J ¼ 7.0, 1H,
CH(CH3)2), 2.58 (hept, 3J ¼ 7.0, 1H, CH(CH3)2), 2.44 (s, 3H, CH3C(O)),
2.04 (s, 6H, (CH3)2C6H3N), 1.89 (s, 6H, (CH3)2C6H3N), 1.19 (d, 3J ¼ 7.0,
6H, (CH3)2CH), 1.00 (d, 3J ¼ 6.9, 6H, (CH3)2CH).
CHHSiMe3), 0.31 (s, 9H, SiMe3), 0.28 (d, 2J ¼ 11.8, 1H, CHHSiMe3). 13
C
4.6. N-(6-(2,6-dimethylphenylamino)pyridin-2-yl)-2-hydroxy-3,5-
diisopropyl-N-(2,6-dimethylphenyl)benzamide
{1H} NMR (125 MHz, C6D6, 298 K):
d 165.6 (NC(CH3)N), 158.5, 155.1,
146.2, 141.9 (p-Py), 141.5, 139.0, 136.5, 135.1, 134.2, 133.1, 129.5,
128.7, 126.7, 126.5, 123.5, 123.2, 93.1 (m-Py), 91.2 (m-Py), 68.8 (
CH2 THF), 51.6 (CH2), 35.9 (CH2SiMe3), 33.6 (CH(CH3)2), 27.5
(CH(CH3)2), 25.1 ( -CH2 THF), 24.4 (CH(CH3)2), 23.9 (CH(CH3)2), 23.1
(CH(CH3)2), 22.8 (CH(CH3)2), 18.9 ((CH3)2C6H3N), 18.3
a
-
2-(N-(6-(2,6-dimethylphenylamino)pyridin-2-yl)-N-(2,6-
dimethylphenyl)carbamoyl)-4,6-diisopropylphenyl acetate (4.20 g,
7.95 mmol) was dissolved in a mixture of MeOH (50 mL) and THF
(70 mL). A 1 M NaOH solution (90 mL) was added dropwise at room
temperature and progress of the reaction was monitored by TLC.
After 5 h, CH2Cl2 (100 mL) was added and the organic phase was
extracted with water (2 ꢂ 200 mL). The organic phases were
combined, dried over Na2SO4 and then filtrated. The resulting so-
lution was passed through a short pad of silica. Volatiles were
evaporated and the white residue was dried to give the desired
b
((CH3)2C6H3N), 18.2 ((CH3)2C6H3N), 17.8 ((CH3)2C6H3N), 3.6 (SiMe3).
Anal. Calcd for C42H58N3O2ScSi: C, 71.05; H, 8.23; N, 5.92. Found: C,
71.70; H, 8.64; N, 6.05.
4.9. {NMe2NNMe2CiPr2O}Y(CH2SiMe3)(THF) (1-Y)
pure product (2.40 g, 61%). 1H NMR (400 MHz, C6D6, 298 K):
d
11.84
NMR-scale Protocol A. In the glove box, a J-Young Teflon-valved
NMR tube was charged with 1-H2 (15.0 mg, 0.030 mmol) and
Y(CH2SiMe3)3(THF)2 (15.0 mg, 0.031 mmol). To this mixture, C6D6
(ca. 0.6 mL) was vacuum-transferred in and the tube was shaken for
15 min at room temperature. 1H NMR spectroscopy indicated that
1-Y formed quantitatively.
Preparative-scale Protocol B. Using a procedure similar to that
described above for 1-Sc, pure 1-Y (420 mg, 86%) was obtained
from 1-H2 (300 mg, 0.591 mmol) and Y(CH2SiMe3)3(THF)2
(292.3 mg, 0.591 mmol) in toluene (5 mL). 1H NMR (400 MHz,
(s, 1H, OH), 7.1 (s, 1H, Ar), 6.94 (m, 7H, Ar), 6.77 (br t, 3J ¼ 7.0, 1H, p-
Py), 6.26 (br m, 1H, m-Py), 5.51 (d, 4J ¼ 7.0, 1H, m-Py), 5.18 (s, 1H,
NH), 3.67 (hept, 3J ¼ 6.9, 1H, CH(CH3)2), 2.57 (hept, 3J ¼ 6.9, 1H,
CH(CH3)2), 2.26 (s, 6H, (CH3)2C6H3N), 1.86 (s, 6H, (CH3)2C6H3N), 1.32
(d, 3J ¼ 6.9, 6H, (CH3)2CH), 1.01 (d, 3J ¼ 6.9, 6H, (CH3)2CH).
4.7. Proligand {NMe2NNMe2CiPr2O}H2 (1-H2)
In a Schlenk flask, N-(6-(2,6-dimethylphenylamino)pyridin-2-
yl)-2-hydroxy-3,5-diisopropyl-N-(2,6-dimethylphenyl)benzamide
(2.2 g, 4.217 mmol) was dissolved in dry THF (15 mL) under argon
atmosphere. BH3$THF (21.0 mL of a 1 M solution in THF, 21.0 mmol)
was added dropwise at 0 ꢁC. The reaction mixture was stirred at
50 ꢁC for 1 h, then cooled down to room temperature and quenched
by addition of a 10% NH4Cl solution (10 mL). Volatiles were evap-
orated and the solid residue was dissolved in CH2Cl2 (50 mL). The
resulting solution was passed through a short pad of silica, the
solution was concentrated under vacuum and the white residue
was recrystallized from methanol to afford the desired proligand as
an analytically pure white powder (0.63 g, 30%). 1H NMR (400 MHz,
C6D6, 298 K):
d
7.25e6.80 (m, 7H, Ar), 6.75 (t, 3J ¼ 8.0, 1H, p-Py),
6.30 (d, 4J ¼ 2.1, 1H, Ar), 5.98 (d, 2J ¼ 13.7, 1H, CHH), 5.29 (d, 3J ¼ 8.0,
1H, m-Py), 5.03 (d, 3J
¼
8.0, 1H, m-Py), 3.98 (3, 2H,
CHH þ CH(CH3)2), 3.80 (br m, 4H, THF), 2.69 (hept, 3J ¼ 6.8, 1H,
CH(CH3)2), 2.46 (s, 3H, (CH3)2C6H3N), 2.37 (s, 3H, (CH3)2C6H3N),
2.14 (s, 3H, (CH3)2C6H3N), 1.55 (s, 3H, (CH3)2C6H3N), 1.49 (d,
3J ¼ 6.8, 3H, (CH3)2CH), 1.40 (d, 3J ¼ 6.8, 3H, (CH3)2CH), 1.28 (br m,
4H, THF), 1.13 (m, 6H, (CH3)2CH), 0.32 (s, 9H, SiMe3), e0.44 (br d,
2J ¼ 11.0, 1H, CHHSiMe3), e0.62 (br d, 2J ¼ 11.0, 1H, CHHSiMe3). 13
C
{1H} NMR (125 MHz, C6D6, 298 K):
d 167.1 (NC(CH3)N), 158.2, 157.1,
147.9, 141.1 (p-Py), 140.7, 139.3, 136.4, 135.8, 135.2, 132.7, 132.2,
128.0, 127.2, 125.9, 123.3, 122.5, 95.1 (m-Py), 91.1 (m-Py), 69.6 (
CH2 THF), 49.4 (CH2), 33.7 (CH(CH3)2), 26.9 (CH(CH3)2), 25.9 (d, 1JY-
-CH2 THF), 24.9 (CH(CH3)2), 24.6
C6D6, 298 K):
d
12.27 (s, 1H, OH), 7.21 (d, 4J ¼ 2.1, 1H, Ar), 6.97 (m,
a-
6H, Ar) 6.72 (t, 3J ¼ 7.0, 1H, p-Py), 6.47 (d, 4J ¼ 2.1, 1H, Ar), 5.96 (s,1H,
NH), 5.28 (d, 3J ¼ 7.0, 2H, m-Py), 4.89 (br s, 2H, CH2), 3.86 (hept,
3J ¼ 6.9, 1H, CH(CH3)2), 2.69 (hept, 3J ¼ 6.9, 1H, CH(CH3)2), 2.17 (s,
6H, (CH3)2C6H3N), 1.78 (s, 6H, (CH3)2C6H3N), 1.49 (d, 3J ¼ 6.9, 6H,
(CH3)2CH), 1.15 (d, 3J ¼ 6.9, 6H, (CH3)2CH). 13C{1H} NMR (100 MHz,
¼ 41.4, CH2SiMe3), 25.7 (
b
C
(CH(CH3)2), 24.0 (CH(CH3)2), 22.7 (CH(CH3)2), 19.6 ((CH3)2C6H3N),
19.5 ((CH3)2C6H3N), 17.9 ((CH3)2C6H3N), 17.8 ((CH3)2C6H3N), 4.2
(SiMe3). Anal. Calcd for C42H58N3O2YSi: C, 66.91; H, 7.75; N, 5.57.
Found: C, 70.12; H, 7.98; N, 5.75.
C6D6, 298 K):
d 156.5 (NC(CH3)N), 156.4 (o-Py), 152.6 (o-Py), 141.1,